The good news that early-stage clinical trials of the Oxford University Covid-19 vaccine candidate (AZD1222), licensed by AstraZeneca pharmaceuticals, is safe and induces an immune response truly gives the world a glimmer of hope at a time when it is facing one of the deadliest pandemic in recent times. Though more tests have to be done before it is made available for public, there is hope for mankind even as the pandemic has already claimed more than six lakh lives and infected millions of people around the globe. Many other nations, including India, are also on the path of developing